Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches
| Autor: | de Jong, Amos J., Zuidgeest, Mira G.P., Santa-Ana-Tellez, Yared, de Boer, Anthonius, Gardarsdottir, Helga |
|---|---|
| Zdroj: | In Drug Discovery Today November 2024 29(11) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect